首页|富血小板血浆联合治疗在慢性创面中的应用及作用机制研究进展

富血小板血浆联合治疗在慢性创面中的应用及作用机制研究进展

扫码查看
慢性创面愈合是一个复杂的过程,内分泌、创伤、缺血和压力损伤等多种因素作用,使创面难以愈合,成为临床治疗中的难点。近年来,富血小板血浆作为一种血小板浓缩物,由于含有丰富的生物活性因子,在创面修复领域展现巨大应用价值。特别是在与传统治疗方法、干细胞疗法及新型材料等技术联合治疗慢性创面时表现协同作用,有效促进创面愈合过程。本文对近年来关于富血小板血浆联合治疗慢性创面的相关研究及可能作用机制进行整理和归纳,旨在为富血小板血浆联合治疗提供更多理论依据,并拓宽慢性创面治疗思路。
Research progress on application and mechanism of platelet rich plasma combination therapy in chronic wounds
Chronic wound healing is a complex process,influenced by various factors such as endocrine,trauma,ischemia,and pressure injuries,making it difficult for wounds to heal and becoming a challenge in clinical treatment.In recent years,platelet rich plasma,as a type of platelet concentrate,has shown great application value in the field of wound repair due to its rich bioactive factors.Especially when combined with traditional treatment methods,stem cell therapy,and new materials to treat chronic wounds,it exhibits a synergistic effect,effectively promoting wound healing process.This article summarizes the relevant research and possible mechanisms of platelet rich plasma combination therapy for chronic wounds in recent years,aiming to provide more theoretical basis for platelet rich plasma combination therapy and broaden the treatment ideas for chronic wounds.

Platelet rich plasmaCombination therapyChronic woundsMechanism

苏志学、刘广星、曾宏宇、黄洪然、黄小玲、唐强

展开 >

右江民族医学院,广西百色 533600

右江民族医学院附属医院烧伤整形与创面修复外科,广西百色 533600

富血小板血浆 联合治疗 慢性创面 机制

2024

中国医药导报
中国医学科学院

中国医药导报

CSTPCD
影响因子:1.759
ISSN:1673-7210
年,卷(期):2024.21(24)